2020-11-30 10:03 |
The pharma firm through its subsidiary Hetero Biopharma intends to start the production of Sputnik V in the beginning of 2021. Russia Direct Investment Fund on November 27 announced their agreement with Hyderabad-based drug maker Hetero Biologics, to produce over 100 million doses of Russia's Covid-19 vaccine Sputnik V in India. The Healthworld.
Подробнее читайте на asiaplustj.info ...